IMMUNOTHERAPEUTIC AGENTS - THEIR ROLE IN CELLULAR-IMMUNITY AND THEIR THERAPEUTIC POTENTIAL

被引：18

作者：

CHIRIGOS, MA ^{[1
]}

TALMADGE, JE ^{[1
]}

机构：

[1] NCI, FREDERICK CANC RES FACIL, PROGRAM RESOURCES INC, PRECLIN SCREENING LAB, FREDERICK, MD 21701 USA

来源：

SPRINGER SEMINARS IN IMMUNOPATHOLOGY | 1985年 / 8卷 / 04期

关键词：

D O I：

10.1007/BF01857388

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：327 / 346

页数：20

共 32 条

[11] LYMPHOKINES - NON-ANTIBODY MEDIATORS OF CELLULAR IMMUNITY GENERATED BY LYMPHOCYTE ACTIVATION [J].

DUMONDE, DC ;

WOLSTENCROFT, RA ;

PANAYI, GS ;

MATTHEW, M ;

MORLEY, J ;

HOWSON, WT .

NATURE, 1969, 224 (5214) :38-+

[12] MINIMAL STRUCTURAL REQUIREMENTS FOR ADJUVANT ACTIVITY OF BACTERIAL PEPTIDOGLYCAN DERIVATIVES [J].

ELLOUZ, F ;

ADAM, A ;

CIORBARU, R ;

LEDERER, E .

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1974, 59 (04) :1317-1325

[13]

FEFER A, 1982, PROGR CANCER RES THE, V22

[14]

FENICHEL R, 1985, IMMUNE MODULATING AG, V25

[15]

GOLDSTEIN AL, 1981, PROGR CANCER RES THE, V20

[16]

HALPER B, 1975, CORYNEBACTERIUM PARV

[17]

HALPERN BN, 1959, CR SOC BIOL, V153, P919

[18]

HERSH E, 1981, PROGR CANCER RES THE, V16

[19]

LOTAN R, 1979, CANCER RES, V39, P55

[20]

LOW TLK, 1982, PROGR CANCER RES THE, V23

← 1 2 3 4 →